Are Global Investment Groups Expecting Further Bullishness on the ASX

It was only last year that there was fear of some economies falling into recession. The pessimism soon dissipated as quickly as it came.

Although the impact of rate cuts cannot be ignored, Global Investing with surging fund flows by retail led to the bullish sentiment.

A strong economic backdrop driven by improving employment data and robust corporate earnings led to this optimism in Global Share Markets.

June survey by Bank of America substantiated by big Global Investment managers validated this as a bull market with potential to run further.

Strong performers led by Nvidia attracted billions from Global Investment Groups. Cash holdings, already at three year lows, can go further down with Global Asset Management companies pumping more money into the Global Shares Equity.

The Two Stocks that have potential to outperform in this environment of cooling inflation and positive market breadth are

Healius Limited (ASX: HLS)

Healius Limited reported its financial results for the half-year ending 31 December 2023 indicating mixed performance.

The Group experienced a 4.9% increase in revenue, reaching $847 million, with Business as Usual (BAU) revenue also growing by the same percentage to $847.4 million. 

Healius Limited's strategic initiatives are positioned to deliver significant benefits to investors. The introduction of upfront payment terminals in the Pathology segment demonstrates a proactive move to diversify revenue streams, reducing reliance on Medicare benefits and potentially bolstering financial stability. 

The company's expansion into new clinical areas and partnerships underscores a commitment to innovation and staying relevant in the market. The emphasis on cost management, facilitated by digitization and rationalization reflects a dedication to operational efficiency, likely contributing to improved profit margins. 

Strategic investments in high-end modalities and the expansion of Lumus Imaging's community sites suggest growth opportunities that can positively impact HLS's market position and revenue. Prudent debt management and the campaign for indexation, addressing secondary costs and improving the overall health of the Pathology segment, contribute to a supportive long-term growth profile.

Codan Limited (ASX: CDA)

Over the span of five years from 2019 to 2023, CDA displayed a robust financial performance marked by impressive growth metrics. The company reported a compelling Compound Annual Growth Rate (CAGR) of 10.98% for revenue and 9.59% for EBITDA, reflecting a consistent and healthy upward trajectory in both top-line and operational profitability. Net cash flow from operations experienced a substantial increase, reaching $131.3 million in 2021, albeit with a temporary dip to $51.72 million in 2022. However, the company rebounded, achieving $78.88 million in FY23. Moreover, Free Cash Flow (FCF) demonstrated a positive trend, rising from $17.56 million in 2022 to $30.51 million in 2023. Despite fluctuations, the total debt-to-equity ratio remained reasonable at 30.8%, underscoring prudent debt management practices and a sustainable capital structure. The strategic investment in engineering positions CDA for future innovation and long-term competitiveness. 

Codan presents a compelling investment opportunity based on its robust performance in the first half of FY24. The company strategically focuses on both the Minelab and Communications segments, highlighting a diversified approach for sustained growth. Key factors contributing to its attractiveness include successful acquisitions (Eagle and Wave Central), demonstrated integration capabilities, and a positive outlook for profitability. Codan's emphasis on technology development, geographic expansion, and winning major contracts in critical sectors highlights its market strength and strategic execution. With a targeted high single-digit revenue growth in the Rest of the World (RoW) market, the company positions itself for future success. Overall, Codan's proactive strategies, strong market presence, and growth potential make it an appealing investment prospect